Use of Medications for Treating Anxiety or Depression among Testicular Cancer Survivors: A Multi-Institutional Study

dc.contributor.authorArdeshirRouhaniFard, Shirin
dc.contributor.authorDinh, Paul C.
dc.contributor.authorMonahan, Patrick O.
dc.contributor.authorFossa, Sophie D.
dc.contributor.authorHuddart, Robert
dc.contributor.authorFung, Chunkit
dc.contributor.authorSong, Yiqing
dc.contributor.authorFeldman, Darren R.
dc.contributor.authorHamilton, Robert J.
dc.contributor.authorVaughn, David J.
dc.contributor.authorMartin, Neil E.
dc.contributor.authorKollmannsberger, Christian
dc.contributor.authorEinhorn, Lawrence
dc.contributor.authorKroenke, Kurt
dc.contributor.authorTravis, Lois B.
dc.contributor.departmentMedicine, School of Medicine
dc.date.accessioned2023-04-13T16:00:12Z
dc.date.available2023-04-13T16:00:12Z
dc.date.issued2021-06
dc.description.abstractBackground: This study examined sociodemographic factors, cisplatin-related adverse health outcomes (AHO), and cumulative burden of morbidity (CBMPt) scores associated with medication use for anxiety and/or depression in testicular cancer survivors (TCS). Methods: A total of 1,802 TCS who completed cisplatin-based chemotherapy ≥12 months previously completed questionnaires regarding sociodemographic features and cisplatin-related AHOs [hearing impairment, tinnitus, peripheral sensory neuropathy (PSN), and kidney disease]. A CBMPt score encompassed the number and severity of cisplatin-related AHOs. Multivariable logistic regression models assessed the relationship of individual AHOs and CBMPt with medication use for anxiety and/or depression. Results: A total of 151 TCS (8.4%) used medications for anxiety and/or depression. No cisplatin-related AHOs were reported by 511 (28.4%) participants, whereas 622 (34.5%), 334 (18.5%), 287 (15.9%), and 48 (2.7%), respectively, had very low, low, medium, and high CBMPt scores. In the multivariable model, higher CBMPt scores were significantly associated with medication use for anxiety and/or depression (P < 0.0001). In addition, tinnitus (P = 0.0009), PSN (P = 0.02), and having health insurance (P = 0.05) were significantly associated with greater use of these medications, whereas being employed (P = 0.0005) and vigorous physical activity (P = 0.01) were significantly associated with diminished use. Conclusions: TCS with higher CBMPt scores had a higher probability of using medications for anxiety and/or depression, and conversely, those who were employed and physically active tended to have reduced use of these medications. Impact: Healthcare providers should encourage TCS to increase physical activity to improve both physical and mental health. Rehabilitation programs should assess work-related skills and provide career development counseling/training.en_US
dc.eprint.versionAuthor's manuscripten_US
dc.identifier.citationArdeshirRouhaniFard S, Dinh PC, Monahan PO, et al. Use of Medications for Treating Anxiety or Depression among Testicular Cancer Survivors: A Multi-Institutional Study. Cancer Epidemiol Biomarkers Prev. 2021;30(6):1129-1138. doi:10.1158/1055-9965.EPI-20-1762en_US
dc.identifier.urihttps://hdl.handle.net/1805/32385
dc.language.isoen_USen_US
dc.publisherAmerican Association for Cancer Researchen_US
dc.relation.isversionof10.1158/1055-9965.EPI-20-1762en_US
dc.relation.journalCancer Epidemiology, Biomarkers & Preventionen_US
dc.rightsPublisher Policyen_US
dc.sourcePMCen_US
dc.subjectAnti-anxiety agentsen_US
dc.subjectAnxietyen_US
dc.subjectDepressionen_US
dc.subjectHearing lossen_US
dc.subjectKidney diseasesen_US
dc.subjectTesticular neoplasmsen_US
dc.subjectTinnitusen_US
dc.titleUse of Medications for Treating Anxiety or Depression among Testicular Cancer Survivors: A Multi-Institutional Studyen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
nihms-1695099.pdf
Size:
136.82 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: